Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 29.
Article
Anderson, RA;
Remedios, R;
Kirkwood, AA;
Patrick, P;
Stevens, L;
Clifton-Hadley, L;
Roberts, T;
... Johnson, PWM; + view all
(2018)
Determinants of Ovarian Function After Response-adapted Therapy in Patients With Advanced Hodgkin's Lymphoma (RATHL): a Secondary Analysis of a Randomised Phase 3 Trial.
Lancet Oncology
, 19
(10)
pp. 1328-1337.
10.1016/S1470-2045(18)30500-X.
|
 |
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Hancock, B;
Pettengell, R;
Johnson, P;
Townsend, W;
... Radford, J; + view all
(2019)
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Journal of Clinical Oncology
, 37
(20)
pp. 1732-1741.
10.1200/JCO.18.01799.
|
|
|
Bishton, MJ;
Rule, S;
Wilson, W;
Turner, D;
Patmore, R;
Clifton-Hadley, L;
McMillan, A;
... Haynes, A; + view all
(2020)
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.
British Journal of Haematology
, 190
(4)
pp. 545-554.
10.1111/bjh.16555.
|
|
Brown, N;
McBain, C;
Nash, S;
Hopkins, K;
Sanghera, P;
Saran, F;
Phillips, M;
... Mulholland, P; + view all
(2016)
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
PLoS ONE
, 11
(5)
10.1371/journal.pone.0156369.
|
|
Camilleri, M;
Sive, J;
Wilson, W;
Pang, G;
Jenner, R;
Phillips, E;
Popat, R;
... Yong, K; + view all
(2021)
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.
British Journal of Haematology
, 192
(1)
E14-E16.
10.1111/bjh.17168.
|
|
Camilleri, M;
Cuadrado, M;
Phillips, E;
Wilson, W;
Jenner, R;
Pang, G;
Kamora, S;
... Yong, K; + view all
(2021)
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
British Journal of Haematology
10.1111/bjh.17377.
(In press).
|
|
|
Chan, WY;
Counsell, N;
de Tute, R;
De-Silva, D;
Phillips, EH;
Cavenagh, J;
Adedayo, T;
... Yong, KL; + view all
(2022)
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.
British Journal of Haematology
, 196
(4)
e33-e37.
10.1111/bjh.17903.
|
|
Chapman, MA;
Sive, J;
Ambrose, J;
Roddie, C;
Counsell, N;
Lach, A;
Abbasian, M;
... Yong, K; + view all
(2018)
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
, 132
(20)
pp. 2154-2165.
10.1182/blood-2018-05-849893.
|
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
|
Gleeson, M;
Counsell, N;
Cunningham, D;
Lawrie, A;
Clifton-Hadley, L;
Hawkes, E;
McMillan, A;
... Linch, D; + view all
(2021)
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial.
British Journal of Haematology
, 192
(6)
pp. 1015-1019.
10.1111/bjh.16691.
|
|
Gohil, SH;
Maciocia, N;
Patrick, P;
Roberts, T;
Counsell, N;
Smith, P;
Clifton-Hadley, L;
... Nathwani, AC; + view all
(2018)
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & Lymphoma
, 59
(7)
pp. 1730-1733.
10.1080/10428194.2017.1399311.
|
|
Hoskin, P;
Popova, B;
Schofield, O;
Brammer, C;
Robinson, M;
Brunt, AM;
Madhavan, K;
... Kirkwood, AA; + view all
(2021)
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
The Lancet Oncology
, 22
(3)
pp. 332-340.
10.1016/S1470-2045(20)30686-0.
|
|
Hough, R;
Lopes, A;
Patrick, P;
Russell, N;
Raj, K;
Tholouli, E;
Snowden, JA;
... Marks, D; + view all
(2022)
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation.
Blood Advances
, 6
(7)
pp. 2414-2426.
10.1182/bloodadvances.2021005106.
|
|
Illidge, TM;
Phillips, EH;
Counsell, N;
Pettengell, R;
Johnson, PWM;
Culligan, DJ;
Popova, B;
... Radford, J; + view all
(2020)
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma.
Blood Advances
, 4
(1)
pp. 203-206.
10.1182/bloodadvances.2019001023.
|
|
|
Latifoltojar, A;
Punwani, S;
Lopes, A;
Humphries, PD;
Klusmann, M;
Menezes, LJ;
Daw, S;
... Taylor, SA; + view all
(2019)
Whole-body MRI for staging and interim response monitoring
in paediatric and adolescent Hodgkin's lymphoma: a comparison
with multi-modality reference standard including 18F-FDG-PET-CT.
European Radiology
, 29
(1)
pp. 202-212.
10.1007/s00330-018-5445-8.
|
|
|
McMillan, AK;
Phillips, EH;
Kirkwood, AA;
Barrans, S;
Burton, C;
Rule, S;
Patmore, R;
... Linch, DC; + view all
(2020)
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
Annals of Oncology
10.1016/j.annonc.2020.05.016.
(In press).
|
|
|
Megias, D;
Phillips, M;
Clifton-Hadley, L;
Harron, E;
Eaton, DJ;
Sanghera, P;
Whitfield, G;
(2017)
Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme.
British Journal Of Radiology
, 90
(1071)
, Article 20160829. 10.1259/bjr.20160829.
|
|
|
Mikhaeel, NG;
Cunningham, D;
Counsell, N;
McMillan, A;
Radford, JA;
Ardeshna, KM;
Lawrie, A;
... Barrington, SF; + view all
(2021)
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study.
British Journal of Haematology
, 192
(3)
pp. 504-513.
10.1111/bjh.16875.
|
|
Mitchell, RJ;
Kirkwood, AA;
Barretta, E;
Clifton-Hadley, L;
Lawrie, E;
Lee, S;
Leongamornlert, D;
... Fielding, AK; + view all
(2021)
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Blood Advances
, 5
(17)
pp. 3322-3332.
10.1182/bloodadvances.2021004430.
|
|
|
Moorman, Anthony;
Butler, Ellie;
Barretta, Emilio;
Kirkwood, Amy A;
Schwab, Claire;
Creasey, Thomas;
Leongamornlert, Daniel A;
... Enshaei, Amir; + view all
(2021)
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
10.1038/s41375-021-01448-2.
(In press).
|
|
|
Phillips, EH;
Lannon, M;
Lopes, A;
Chadwick, H;
Jones, G;
Sieniawski, M;
Davies, A;
... Lennard, A; + view all
(2019)
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
[Letter].
Bone Marrow Transplantation
, 54
pp. 465-468.
10.1038/s41409-018-0294-2.
|
|
Phillips, EH;
Nash, S;
Adedayo, T;
Whelan, CJ;
Fontana, M;
Mahmood, S;
Lachmann, HJ;
... Wechalekar, AD; + view all
(2017)
Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study.
Amyloid
, 24
(4)
pp. 250-252.
10.1080/13506129.2017.1385453.
|
|
Popat, R;
Counsell, N;
De Tute, R;
De-Silva, D;
Phillips, EH;
Cavenagh, JD;
Adedayo, T;
... Yong, K; + view all
(2021)
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
British Journal of Haematology
, 193
(3)
e19-e22.
10.1111/bjh.17391.
|
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2021)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/jco.21.00917.
(In press).
|
|
|
Rossig, C;
Pule, M;
Altvater, B;
Saiagh, S;
Wright, G;
Ghorashian, S;
Clifton-Hadley, L;
... Amrolia, PJ; + view all
(2017)
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.
Leukemia
, 31
pp. 1087-1095.
10.1038/leu.2017.39.
|
|
Rule, S;
Cook, G;
Russell, NH;
Hunter, A;
Robinson, S;
Morley, N;
Sureda, A;
... Peggs, KS; + view all
(2019)
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
British Journal of Haematology
, 184
(6)
pp. 999-1005.
10.1111/bjh.15723.
|
|
Townsend, W;
Leong, S;
Hoskin, P;
Diez, P;
Patrick, P;
Linch, D;
Wong, W-L;
... Ardeshna, K; + view all
(2019)
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
British Journal of Haematology
10.1111/bjh.16296.
(In press).
|
|
|
Watts, C;
Ashkan, K;
Jenkinson, MD;
Price, SJ;
Santarius, T;
Matys, T;
Zhang, TT;
... Counsell, N; + view all
(2021)
An evaluation of the tolerability and feasibility of combining 5-amino-levulinic acid (5-ala) with bcnu wafers in the surgical management of primary glioblastoma.
Cancers
, 13
, Article 3241. 10.3390/cancers13133241.
|
|
